Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Terminated 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Breast 3Dermatologic 2Other neoplasm 1Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 3Radiation Injuries 1Breast Carcinoma In Situ 1

Interventions

Trastuzumab 349Paclitaxel 310Cyclophosphamide 286Docetaxel 267Carboplatin 215Capecitabine 215Letrozole 185Fulvestrant 178Doxorubicin 166Bevacizumab 136Anastrozole 120Tamoxifen 117pertuzumab 114pembrolizumab 113Epirubicin 110exemestane 107Vinorelbine 106Gemcitabine 106Albumin-Bound Paclitaxel 92Lapatinib 84130-nm albumin-bound paclitaxel 83Radiotherapy 79palbociclib 75eribulin 73Cisplatin 69pyrotinib 66Taxes 65Everolimus 55Goserelin 50Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Lovastatin × Breast × Clear all
NCT07619365 2026-06-02

Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer

Washington University School of Medicine

Phase 2 Not yet recruiting
60 enrolled
Breast

Breast Neoplasms

NCT00285857 2017-03-09

Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention

Stanford University

Phase 2 Terminated
30 enrolled 7 charts
Breast

Breast Neoplasms

NCT00902668 2013-06-20

Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer

Virginia Commonwealth University

Phase 2 Terminated
3 enrolled 4 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡